Personalized medicine leverages decades of breakthroughs in science and healthcare to provide patients with precise treatment options for their specific case. Ashion® is dedicated to accelerating the use of personalized genomic information to provide patients with the right treatment for their disease.
Easy-to-Understand Reports
The GEM ExTra® Report summarizes the key findings from your genomic test in an easy-to-read format. The report focuses on the damaged gene(s) identified in your cancer cells to identify option(s) for your personalized treatment. This report is meant for your healthcare provider to review with you.
Outlines information about you, your doctor and your blood and tumor samples.
The Genomic Snapshot table gives your oncologist a quick summary of key results found in the report.
The Findings Table contains more details about the findings listed in Section 3, as well as additional information for your doctor.
BLUE: List of Genomic Alterations found in your cancer.
GREEN: Evidence for drug treatments predicted to be effective by your test results.
YELLOW: List of clinical trials you may be eligible for based on your test results.
States your cancer diagnosis as provided by your doctor when ordering the test. This is not based on the GEM ExTra® test results.
The Tumor Genomic Alterations are the headline findings of the report. It is a list of genes identified as being damaged in your cancer but not in your normal DNA (“normal” DNA is obtained from your blood; reported information is obtained from your tumor DNA). These are the key genes that will inform you and your doctor as you make your personalized treatment decisions.